Cargando…
Durable Improvement in Generic and Fibroid-Specific Quality of Life in Women Treated with Transcervical Fibroid Ablation with the Sonata System After Three Years
OBJECTIVE: To determine quality-adjusted life years (QALYs) over 3 years after transcervical fibroid ablation (TFA) with the Sonata System. METHODS: The SONATA trial was a prospective multicenter interventional trial that assessed the safety and efficacy of TFA for treatment of women with symptomati...
Autores principales: | Roy, Kelly, Robinson, James K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048174/ https://www.ncbi.nlm.nih.gov/pubmed/35497488 http://dx.doi.org/10.1089/gyn.2021.0073 |
Ejemplares similares
-
Transcervical fibroid ablation with the Sonata™ system for treatment of submucous and large uterine fibroids
por: Shifrin, Gregory, et al.
Publicado: (2021) -
Pregnancy Outcomes After Transcervical Radiofrequency Ablation of Uterine Fibroids with the Sonata System
por: Christoffel, Ladina, et al.
Publicado: (2022) -
Three-Year Results of the SONATA Pivotal Trial of Transcervical Fibroid Ablation for Symptomatic Uterine Myomata
por: Lukes, Andrea, et al.
Publicado: (2020) -
A New Paradigm for Uterine Fibroid Treatment: Transcervical, Intrauterine Sonography-Guided Radiofrequency Ablation of Uterine Fibroids with the Sonata System
por: Toub, David B.
Publicado: (2017) -
Transcervical Radiofrequency Ablation of Symptomatic Uterine Fibroids: 2-Year Results of the SONATA Pivotal Trial
por: Miller, Charles E., et al.
Publicado: (2019)